Liminatus Pharma Inc. Class A-28LIMNW Preferred / convertible 13F holders, Q2 2025 (June 30) 25 holders
1 famous investor
$0.23 avg. 13F price*
At the end of Q2 2025 , 25 institutions reported holding Liminatus Pharma Inc. Class A-28 (LIMNW) in their 13F filings. The largest holders were Cantor Fitzgerald, L. P. ($210K), Clear Street LLC ($193K) and Aristeia Capital, L.L.C. ($67K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
Company Liminatus Pharma Inc. Class A-28
CUSIP 53271X116
Latest filing quarter Q2 2026 History Number of 13F holders
Total Exit/New Position Q2 2025 Institutions Total Value New Positions 24 $799K Exits 0 $0
Ownership 25 holders Portfolio Manager % of Holder's Portfolio Change Shares Value ▼ Cantor Fitzgerald, L. P. — New 875,817 $210K Clear Street LLC — New 805,477 $193K Aristeia Capital, L.L.C. — New 313,238 $67K Linden Advisors LP — New 268,199 $56K Saba Capital Management, L.P. — New 233,761 $56K Moore Capital Management, LP — New 125,000 $30K MMCAP International Inc. SPC — New 111,745 $27K Polar Asset Management Partners Inc. — New 122,688 $26K Wolverine Asset Management LLC — New 102,987 $25K Alpha Wave Global, LP — New 89,098 $22K D. E. Shaw & Co. — New 83,353 $20K Periscope Capital Inc. — New 50,000 $12K Blue Owl Capital Holdings LP — New 50,000 $12K Toronto Dominion Bank — New 35,200 $8K LMR Partners LLP — New 29,961 $7K Arena Capital Advisors, LLC- CA — New 29,166 $7K Jane Street Group, LLC — New 26,943 $6K Limestone Investment Advisors LP — — 22,562 $5K Cubist Systematic Strategies, LLC — New 15,778 $4K Meteora Capital, LLC — New 15,000 $4K Flow Traders U.S. LLC — New 13,110 $3K Dupont Capital Management Corp. — New 6,250 $2K UBS Group AG — New 2,020 $485 HGC Investment Management Inc. — New 1,250 $300 Bank of America Corp. — New 300 $72
"% of holder's portfolio" is LIMNW's weight in each manager's 13F, not the share of Liminatus Pharma Inc. Class A-28 the manager owns.